Invention Grant
- Patent Title: Inositol derivatives for use in pathological crystallization
-
Application No.: US16852587Application Date: 2020-04-20
-
Publication No.: US11028112B2Publication Date: 2021-06-08
- Inventor: Mattias Ivarsson , Bastien Castagner , Jean-Christophe Leroux , Andreas Pasch
- Applicant: ETH Zurich , UNIVERSITÄT BERN
- Applicant Address: CH Zurich; CH Bern
- Assignee: ETH Zurich,UNIVERSITÄT BERN
- Current Assignee: ETH Zurich,UNIVERSITÄT BERN
- Current Assignee Address: CH Zurich; CH Bern
- Agency: JMB Davis Ben-David
- Priority: EP15199682 20151211,EP16164299 20160407,EP16173422 20160607
- Main IPC: C07H15/08
- IPC: C07H15/08 ; A61K47/34 ; A61P9/10
Abstract:
The present invention relates to inositol derivatives covalently modified with one, two or three solubility functions, particularly polyethylene glycol moieties, for use in therapy or prevention of conditions related to pathological calcium crystallization, such as cardiovascular calcifications, nephrocalcinosis, calcinosis cutis, chondrocalcinosis and kidney stones.
Public/Granted literature
- US20200247837A1 INOSITOL DERIVATIVES FOR USE IN PATHOLOGICAL CRYSTALLIZATION Public/Granted day:2020-08-06
Information query
IPC分类:
